Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug 1;110(8):797-798.
doi: 10.1093/jnci/djy008.

Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks

Hormuzd A Katki  1 , Mark H Greene  1 , Maria Isabel Achatz  1
Affiliations
Comment

Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks

Hormuzd A Katki et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Offit K. Multigene testing for hereditary cancer: When, why, and how. J Natl Compr Canc Netw. 2017;15(5S):741–743. - PubMed
    1. Rana HQ,, Gelman R, LaDuca H. et al. Differences in TP53 mutation carrier phenotypes emerge from panel-based testing. J Natl Cancer Inst. 2018;1108:863–870. - PubMed
    1. Villani A, Shore A, Wasserman JD, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016;179:1295–1305.http://dx.doi.org/10.1016/S1470-2045(16)30249-2 - DOI - PubMed
    1. Yanik EL, Katki HA, Engels EA.. Cancer risk among the HIV-infected elderly in the United States. AIDS. 2016;3010:1663–1668.http://dx.doi.org/10.1097/QAD.0000000000001077 - DOI - PMC - PubMed
    1. de Andrade KC, Mirabello L, Stewart DR, et al. Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. Hum Mutat. 2017;3812:1723–1730.http://dx.doi.org/10.1002/humu.23320 - DOI - PMC - PubMed

Publication types